Abstract
Fifteen of 20 hemodialysis patients who carried Staphylococcus aureus in their nares also carried the organism on their hands; 2 of 20 patients who did not carry S aureus in their nares carried S aureus on their hands (P < .001). Eighty-seven percent of patients who carried S aureus in their nares and on their hands carried the same strain at both sites. Intranasal mupirocin eliminated S aureus from both sites.
Publication types
-
Clinical Trial
-
Controlled Clinical Trial
MeSH terms
-
Administration, Intranasal
-
Anti-Bacterial Agents / therapeutic use*
-
Carrier State / drug therapy*
-
Follow-Up Studies
-
Humans
-
Infection Control
-
Mupirocin / therapeutic use*
-
Nasal Mucosa / microbiology*
-
Renal Dialysis
-
Skin / microbiology*
-
Staphylococcal Infections / drug therapy*
-
Staphylococcus aureus*
Substances
-
Anti-Bacterial Agents
-
Mupirocin